DR ZEESHAN BADAR , DR SHEIKH TAHIR SIDDIQUE , DR ZIAUDDIN AHMED , DR ABDUL SAMAD SHAIKH , DR ABDUL GHAFFAR SHAIKH , DR FARYAL AZHAR. EFFICACY AND SAFETY OF RITUXIMAB PLUS DOSE ADJUSTED ETOPOSIDE, PREDNISONE, VINCRISTINE, CYCLOPHOSPHAMIDE AND DOXORUBICIN (R-DA-EPOCH) REGIMEN IN HIGH GRADE DIFFUSE LARGE B- CELL LYMPHOMA PATIENTS (HG-DLBCL). TPM – Testing, Psychometrics, Methodology in Applied Psychology, [S. l.], v. 32, n. S8 (2025): Posted 05 November, p. 2910–2915, 2025. DOI: 10.5281/zenodo.18456651. Disponível em: https://tpmap.org/submission/index.php/tpm/article/view/4054. Acesso em: 5 apr. 2026.